T Lottenburger

Overview

Explore the profile of T Lottenburger including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 18

Citations 274

Followers 0

Related Specialties

Rheumatology

Allergy & Immunology

Biochemistry

Top 10 Co-Authors

K Horslev-Petersen

P Junker

H Lindegaard

T Ellingsen

M Ostergaard

M L Hetland

K Stengaard-Pedersen

I Hansen

J K Pedersen

U Tarp

Published In

Scand J Rheumatol

Ann Rheum Dis

Scand J Immunol

Clin Exp Rheumatol

Biomarkers

Affiliations

Soon will be listed here.

Recent Articles

Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial

Brahe C, Ostergaard M, Johansen J, Defranoux N, Wang X, Bolce R, et al.

Scand J Rheumatol . 2018 Jul; 48(1):9-16. PMID: 29985080

Objectives: Measurement of serum biomarkers at disease onset may improve prediction of disease course in patients with early rheumatoid arthritis (RA). We evaluated the multi-biomarker disease activity (MBDA) score and...

Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and...

Brahe C, Dehlendorff C, Ostergaard M, Johansen J, Ornbjerg L, Horslev-Petersen K, et al.

Scand J Rheumatol . 2018 Jan; 47(4):259-269. PMID: 29336711

Objective: To investigate serum interleukin-6 (IL-6), serum chitinase-3-like protein-1 (YKL-40), and plasma vascular endothelial growth factor (VEGF) as measures of disease activity and predictors of clinical remission and radiographic progression...

Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity

Issa S, Christensen A, Lindegaard H, Hetland M, Horslev-Petersen K, Stengaard-Pedersen K, et al.

Scand J Immunol . 2017 Oct; 86(6):471-478. PMID: 28990250

Galectin-3 has been suggested as a pro-inflammatory mediator in animal arthritis and rheumatoid arthritis (RA). We aimed to study the serum level of galectin-3 in patients with newly diagnosed RA...

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial

Ornbjerg L, Ostergaard M, Jensen T, Horslev-Petersen K, Stengaard-Pedersen K, Junker P, et al.

Clin Rheumatol . 2016 Dec; 36(4):781-789. PMID: 27921185

This study aims to investigate 1-year hand bone loss (HBL) in early rheumatoid arthritis (RA) patients treated with a methotrexate (MTX) and intra-articular triamcinolone treat-to-target strategy +/- adalimumab and to...

Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid...

Moller-Bisgaard S, Ejbjerg B, Eshed I, Horslev-Petersen K, Hetland M, Jurik A, et al.

Scand J Rheumatol . 2016 Nov; 46(5):335-345. PMID: 27775461

Objectives: To investigate whether a treat-to-target strategy based on methotrexate (MTX) and intra-articular (IA) betamethasone suppresses magnetic resonance imaging (MRI)-determined measures of disease activity and reduces joint destruction in early...

Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

Horslev-Petersen K, Hetland M, Ornbjerg L, Junker P, Podenphant J, Ellingsen T, et al.

Ann Rheum Dis . 2015 Oct; 75(9):1645-53. PMID: 26489704

Objectives: To study clinical and radiographic outcomes after withdrawing 1 year's adalimumab induction therapy for early rheumatoid arthritis (eRA) added to a methotrexate and intra-articular triamcinolone hexacetonide treat-to-target strategy (NCT00660647)....

Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals

Issa S, Christensen A, Lottenburger T, Junker K, Lindegaard H, Horslev-Petersen K, et al.

Scand J Immunol . 2015 Apr; 82(1):70-5. PMID: 25857722

Galectin-3 has been suggested as a pro-inflammatory mediator in rheumatoid arthritis (RA). Previous studies have reported overexpression of Galectin-3 in RA synovitis and increased levels in synovial fluid and serum...

Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis

Krol A, Garred P, Heegaard N, Christensen A, Hetland M, Stengaard-Pedersen K, et al.

Scand J Rheumatol . 2014 Sep; 44(1):8-12. PMID: 25205362

Objectives: To determine to what extent shared epitopes, smoking, and anti-cyclic citrullinated peptide (anti-CCP) antibodies are associated with disease activity and erosive disease in patients with rheumatoid arthritis (RA) at...

Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression

Ellingsen T, Hansen I, Thorsen J, Moller B, Tarp U, Lottenburger T, et al.

Scand J Rheumatol . 2013 Aug; 43(2):91-100. PMID: 23980529

Objectives: The aim of this study was to measure, in early rheumatoid arthritis (RA) patients, the concentration of CC-chemokine ligand 19 (CCL19) in plasma and the cell-surface expression of CC-chemokine...

10.

Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial

Jensen T, Hansen M, Horslev-Petersen K, Hyldstrup L, Abrahamsen B, Langdahl B, et al.

Ann Rheum Dis . 2013 May; 73(6):1123-9. PMID: 23661492

Objectives: The aims of this study were to investigate the influence of alendronate and intra-articular betamethasone treatment on bone mineral density (BMD) changes in hand, lumbar spine and femoral neck...